Intraventricular Antimicrobial Therapy for Intractable Ventriculitis: Two Case Reports
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
뇌실염은 일반적으로 정맥 내 항생제를 통하여 치료하나, 불응성 뇌실염의 치료는 정맥 내 항생제 치료와 뇌실 내 항생제 치료의 병행이 요구되기도 한다. 이론적으로 항생제의 뇌실 내 투여는 정맥 내 단독 투여보다 뇌척수액에서 더 높은항생제 농도에 도달할 수 있게 한다. 본 증례 보고는 기존의 전신 항생제 치료에 불응하는 폐렴 간균과 메티실린 내성 표피 포도상 구균에 각각 뇌실 내 겐타마이신과 반코마이신 투여를 통하여 뇌실염을 치료한 2례로서 이후에도 주요 합병증 등이 없어 이를 보고하는 바이다.
Abstract
It is challenging to treat ventriculitis with parenteral treatment alone in some cases because of the difficulty involved in maintaining an appropriate level of antibiotics in cerebrospinal fluid (CSF). We report two cases of ventriculitis who did not respond to intravenous (IV) antibiotics but were successfully treated with intraventricular antibiotics using IV agents. The first case was a four-month-old male patient with X-linked hydrocephalus. He showed ventriculitis due to Klebsiella pneumoniae not producing extended-spectrum β-lactamase and susceptible to third-generation cephalosporins and gentamicin, following ventriculoperitoneal (VP) shunt. His condition did not improve during the 47 days of treatment with IV cefotaxime and meropenem. We achieved improvement in clinical presentation and CSF profile after three times of intraventricular gentamicin injection. The patient was discharged from the hospital with antiepileptic drugs. The second case was a six-month-old female patient with a history of neonatal meningitis complicated with hydrocephalus at one month of age, VP shunt at two months of age, followed by a methicillinresistant coagulase-negative staphylococci (CoNS) shunt infection with ventriculitis after the shunt operation. CoNS ventriculitis recurred four weeks later. We failed to treat intractable methicillin-resistant CoNS ventriculitis with IV vancomycin for ten days, and thus intraventricular antimicrobial treatment was considered. Five times of intraventricular vancomycin administration led to improvement in clinical parameters. There were only neurological sequelae of delayed language development but no other major complications. Patients in these two cases responded well to intraventricular antibiotics, with negative CSF culture results, and were successfully treated for ventriculitis without serious complications.
참고문헌 (20)
- Tunkel AR, "2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis", Clin Infect Dis, 64, pp.e34~65 (2017)
- "Ventriculitis" (2021)[URL]
- Unhanand M, "Gram-negative enteric bacillary meningitis : a twenty-one-year experience", J Pediatr, 122, pp.15~21 (1993)
- Ziai WC, "Improving the role of intraventricular antimicrobial agents in the management of meningitis", Curr Opin Neurol, 22, pp.277~282 (2009)
- Nau R, "Intrathecal antibacterial and antifungal therapies", Clin Microbiol Rev, 33, pp.e00190~19 (2020)
- Mrowczynski OD, "Intra-cerebrospinal fluid antibiotics to treat central nervous system infections : a review and update", Clin Neurol Neurosurg, 170, pp.140~158 (2018)
- Khan SA, "Intrathecal and intraventricular antibiotics for postoperative gram-negative meningitis and ventriculitis", Surg Neurol Int, 8, pp.226~ (2017)
- Ng K, "Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults", Neurocrit Care, 20, pp.158~171 (2014)
- Pfausler B, "Cerebrospinal fluid(CSF)pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage", Clin Infect Dis, 25, pp.733~735 (1997)
- Matsunaga N, "An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases", Medicine(Baltimore), 94, pp.e922~ (2015)
- Cook AM, "Intracerebroventricular administration of drugs", Pharmacotherapy, 29, pp.832~845 (2009)
- LeBras M, "Systematic review of efficacy, pharmacokinetics, and administration of intraventricular aminoglycosides in adults", Neurocrit Care, 25, pp.492~507 (2016)
- Klibanov OM, "Sensorineural hearing loss associated with intrathecal vancomycin", Ann Pharmacother, 37, pp.61~65 (2003)
- He Z, "Successful treatment of serious meningitis caused by extremely carbapenem-resistant Enterobacter cloacae (MIC≥16mg", L) with i.v. meropenem and i.v. amikacin plus intraventricular amikacin, 2019, pp.12, 3765~3770
- Wang JH, "Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis : a hospital-based retrospective study", J Microbiol Immunol Infect, 47, pp.204~210 (2014)
- Lewin JJ 3rd, "Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis : results from a multicenter retrospective cohort study", Neurocrit Care, 30, pp.609~616 (2019)
- Wilkie MD, "Infections of cerebrospinal fluid diversion devices in adults : the role of intraventricular antimicrobial therapy", J Infect, 66, pp.239~246 (2013)
- Tängdén T, "Neurosurgical gram-negative bacillary ventriculitis and meningitis : a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases", Clin Infect Dis, 52, pp.1310~1316 (2011)
- Chen K, "The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy", J Crit Care, 30, pp.218.e1~218.e5 (2015)
- Grabb PA, "Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia : report of two patients", Neurosurgery, 30, pp.630~634 (1992)